The LAI PrEP Journey

Target Audience

This activity is designed to educate primary care, sexual health, women’s health, and infectious disease and HIV specialist physicians, nurse practitioners (NPs), and physician assistants (PAs) related to providing LAI PrEP services across critical junctures in a patient’s life.

Program Overview

Preexposure prophylaxis (PrEP) is an essential tool to help end the HIV epidemic. In this case-based interactive activity, you will learn practical tips for initiating sexual health discussions, and selecting and managing PrEP regimens, from initiation to monitoring and follow-up. The case follows a patient’s experience using long-acting injectable PrEP throughout many changes in lifestyle and PrEP regimen needs. Aniruddha Hazra, MD and Joshua Havens, PharmD will review clinical evidence for PrEP options, and discuss strategies and best practices for implementing long-acting injectable PrEP, placed in the context of case-based mile markers along the PrEP Journey.

Educational Objectives

After completing this activity, the participant should be better able to:

1. Identify shared decision-making strategies for selecting PrEP based on patient preferences and characteristics
2. Implement required laboratory testing for LAI PrEP initiation and monitoring
3. Determine clinical practice strategies to streamline provision of LAI PrEP
4. Describe clinical considerations for managing discontinuation and restarting of LAI PrEP

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Continuing Medical Education

Integritas designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Reciprocity Statement

The ANCC’s Commission on Accreditation recognizes educational activities that are approved for AMA PRA Category 1 Credits™ by providers who are accredited by the ACCME to award credit to learners. This reciprocity agreement allows nurses and nurse practitioners to use AMA PRA Category 1 Credits™ as approved ANCC contact hours for license renewal.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Integritas Contact Information

For more information about the approval of this program, please contact Integritas at info@exchangecme.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must:

1. Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
2. Complete the Preactivity Questions.
3. Review the activity content.
4. Achieve a grade of at least 70% on the Postactivity Test Questions and complete the Evaluation.

Disclosures of Conflicts of Interest

Integritas adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Integritas are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Josh Havens, PharmD: Consulting fees: Merck, Viiv Healthcare; Contracted Research: Gilead Sciences

Aniruddha Hazra, MD: Consulting fees: Abbott Technologies, Gilead Sciences, ViiV Healthcare; Contracted Research: Gilead Sciences

The Integritas Communications planners and managers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas does not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.